Barclays PLC
- SEC CIK
- 0000312069
- Latest filing
- Aug 14, 2026
FULC holding history
Fulcrum Therapeutics, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FULC overviewAll 13F holders of FULCFull Q2 2026 holdings
- Shares (Q2 2026)
- 83,373
- Value
- $305.1K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 83,373 | $305.1K | <0.1% | −5,085−5.7% | Reduced | Holders |
| Q1 2026 | 88,458 | $678.5K | <0.1% | −44,083−33.3% | Reduced | Holders |
| Q4 2025 | 132,541 | $1.50M | <0.1% | +42,925+47.9% | Added | Holders |
| Q3 2025 | 89,616 | $824.5K | <0.1% | −22,447−20.0% | Reduced | Holders |
| Q2 2025 | 112,063 | $771.0K | <0.1% | +29,606+35.9% | Added | Holders |
| Q1 2025 | 82,457 | $237.5K | <0.1% | −39,613−32.5% | Reduced | Holders |
| Q4 2024 | 122,070 | $573.7K | <0.1% | −2,071−1.7% | Reduced | Holders |
| Q3 2024 | 124,141 | $443.2K | <0.1% | +97,565+367.1% | Added | Holders |
| Q2 2024 | 26,576 | $164.8K | <0.1% | −44,939−62.8% | Reduced | Holders |
| Q1 2024 | 71,515 | $675.1K | <0.1% | +3,330+4.9% | Added | Holders |
| Q4 2023 | 68,185 | $460.2K | <0.1% | +68,185 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −144,983−100.0% | Sold out | Holders |
| Q2 2023 | 144,983 | $478.4K | <0.1% | +117,730+432.0% | Added | Holders |
| Q1 2023 | 27,253 | $77.7K | <0.1% | +15,561+133.1% | Added | Holders |
| Q4 2022 | 11,692 | $85.1K | <0.1% | +10,244+707.5% | Added | Holders |
| Q3 2022 | 1,448 | $12.0K | <0.1% | −265−15.5% | Reduced | Holders |
| Q2 2022 | 1,713 | $8.00K | <0.1% | −21,667−92.7% | Reduced | Holders |
| Q1 2022 | 23,380 | $553.0K | <0.1% | +23,380 | New | Holders |